<div>Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis</div>

Claris CEO, Clarke Atwell, gives an update on the company and their path toward developing treatment for neurotrophic keratitis

S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

<div>Hosted by the award-winning editorial staff of <strong>Ophthalmology Times®</strong>, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry.</div>

Science

Life Sciences

Hosted by the award-winning editorial staff of Ophthalmology Times®, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry.

Hosted by the award-winning editorial staff of <strong>Ophthalmology Times®</strong>, EyePod podcasts feature the latest updates and resources most relevant to professionals across the eyecare industry.

Share S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

Sign up to save your podcasts

S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis

S2 Ep38: Claris Bio's journey toward treating neurotrophic keratitis